These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7697901)

  • 1. Effective nonsteroidal anti-inflammatory drugs devoid of gastrointestinal side effects: do they really exist?
    Lancaster C
    Dig Dis; 1995 Jan; 13 Suppl 1():40-7. PubMed ID: 7697901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile and mechanisms of gastrointestinal and other side effects of nonsteroidal anti-inflammatory drugs (NSAIDs).
    Rainsford KD
    Am J Med; 1999 Dec; 107(6A):27S-35S; discussion 35S-36S. PubMed ID: 10628591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsteroidal anti-inflammatory drugs: how do they damage gastroduodenal mucosa?
    Scarpignato C
    Dig Dis; 1995 Jan; 13 Suppl 1():9-39. PubMed ID: 7697906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prodrugs of Non-steroidal Anti-inflammatory Drugs (NSAIDs): A Long March Towards Synthesis of Safer NSAIDs.
    Sehajpal S; Prasad DN; Singh RK
    Mini Rev Med Chem; 2018; 18(14):1199-1219. PubMed ID: 29600762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gastrointestinal lesions produced by nonsteroidal anti-inflammatory agents: the clinical manifestations, risk factors, physiopathology, prevention and treatment].
    Martín de Argila C; Moreira V; Gisbert JP
    An Med Interna; 1995 Feb; 12(2):85-96. PubMed ID: 7749017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal safety of low-dose aspirin.
    Cryer B
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S701-8. PubMed ID: 12512737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal side effects of nonsteroidal anti-inflammatory drugs.
    Cryer B; Kimmey MB
    Am J Med; 1998 Jul; 105(1B):20S-30S. PubMed ID: 9715831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal effects of NSAIDs. Difficulties in detection and management.
    Pearson SP; Kelberman I
    Postgrad Med; 1996 Nov; 100(5):131-2, 135-6, 141-3. PubMed ID: 8917329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in managing NSAID-associated gastrointestinal tract injury.
    Goldstein JL
    Digestion; 2004; 69 Suppl 1():25-33. PubMed ID: 15001832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal anti-inflammatory drug and phospholipid prodrugs: combination therapy with antisecretory agents in rats.
    Lichtenberger LM; Ulloa C; Romero JJ; Vanous AL; Illich PA; Dial EJ
    Gastroenterology; 1996 Oct; 111(4):990-5. PubMed ID: 8831593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury.
    Agrawal NM; Dajani EZ
    Int J Clin Pharmacol Res; 1989; 9(6):347-57. PubMed ID: 2576801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract.
    Hirschowitz BI
    Gastroenterologist; 1994 Sep; 2(3):207-23. PubMed ID: 7987619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Droxicam: a pharmacological and clinical review of a new NSAID.
    Jané F; Rodríguez de la Serna A
    Eur J Rheumatol Inflamm; 1991; 11(4):3-9. PubMed ID: 1365488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 1994 Merck Frosst Award. Mechanisms of nonsteroidal anti-inflammatory drug (NSAID) induced gastrointestinal damage--potential for development of gastrointestinal tract safe NSAIDs.
    Wallace JL
    Can J Physiol Pharmacol; 1994 Dec; 72(12):1493-8. PubMed ID: 7736340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic Strategies Towards Safer NSAIDs Through Prodrug Approach: A Review.
    Gupta K; Chawla PA; Sharma D
    Mini Rev Med Chem; 2021; 21(15):2065-2102. PubMed ID: 33390114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety profiles of leading nonsteroidal anti-inflammatory drugs.
    Rothstein R
    Am J Med; 1998 Nov; 105(5A):39S-43S. PubMed ID: 9855175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. True or false? Challenges and recent highlights in the development of aspirin prodrugs.
    Willetts S; Foley DW
    Eur J Med Chem; 2020 Apr; 192():112200. PubMed ID: 32163816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastro-intestinal lesions induced by non-steroidal anti-inflammatory drugs.
    Albu R; Dragomir P; Voiosu R
    Rom J Intern Med; 1998; 36(3-4):145-59. PubMed ID: 10822511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.